Apple News Facebook Twitter 新浪微博 Instagram YouTube Friday, May 10, 2024
Search
Archive
English>>

EU says to purchase up to 300 mln doses of BioNTech/Pfizer vaccine

(Xinhua)    08:42, November 11, 2020

BRUSSELS, Nov. 10 (Xinhua) -- The European Union (EU) will authorize a contract for the purchase of up to 300 million doses of the COVID-19 vaccine jointly developed by German company BioNTech and its American partner Pfizer, European Commission President Ursula von der Leyen said on Tuesday.

"This is the most promising vaccine so far," she said on Twitter. The contract, due to be reached on Wednesday, will be the fourth one the EU secures with a pharmaceutical company to buy vaccines for COVID-19.

The BioNTech/Pfizer vaccine candidate has proved to be more than 90 percent effective in preventing COVID-19 infection in participants with no proven previous SARS-CoV-2 infection, the two companies announced on Monday.

As the world is struggling to contain the COVID-19 pandemic, countries including Germany, China, Russia, the United Kingdom and the United States are racing to find a vaccine.

According to the website of the World Health Organization, as of Nov. 3, there were 202 COVID-19 candidate vaccines being developed worldwide, and 47 of them were in clinical trials.

(For the latest China news, Please follow People's Daily on Twitter and Facebook)(Web editor: Wen Ying, Bianji)

We Recommend

Most Read

Key Words